Skip to main content

Advertisement

SpringerLink
Log in

Disparities in Surgical Oncology: Management of Advanced Cancer

  • Global Health Services Research
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Significant variations in the patterns of care, incidence, and mortality rates of several common cancers have been noted. These disparities have been attributed to a complex interplay of factors, including genetic, environmental, and healthcare-related components. Within this review, primarily focusing on commonly occurring cancers (breast, lung, colorectal), we initially summarize the burden of these disparities with regard to incidence and screening patterns. We then explore the interaction between several proven genetic, epigenetic, and environmental influences that are known to contribute to these disparities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372.

    PubMed  PubMed Central  Google Scholar 

  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

    PubMed  Google Scholar 

  3. DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. CA Cancer J Clin. 2019;69(3):211–33.

    PubMed  Google Scholar 

  4. National Cancer Institute. SEER cancer stat facts: cancer disparities [cited 13 Mar 2021]. https://seer.cancer.gov/statfacts/html/disparities.html.

  5. Smith CJ, Minas TZ, Ambs S. Analysis of tumor biology to advance cancer health disparity research. Am J Pathol. 2018;188(2):304–16.

    PubMed  PubMed Central  Google Scholar 

  6. Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124(2):315–32.

    PubMed  Google Scholar 

  7. National Cancer Institute. SEER cancer facts SEER.

  8. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

    PubMed  Google Scholar 

  9. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354(4):333–42.

    CAS  PubMed  Google Scholar 

  10. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.

    PubMed  Google Scholar 

  11. Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36(1):25–33.

    CAS  Google Scholar 

  12. Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong Y-N, Edge SB, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33(20):2254.

    PubMed  PubMed Central  Google Scholar 

  13. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.

    CAS  PubMed  Google Scholar 

  14. Wu AH, Gomez SL, Vigen C, Kwan ML, Keegan TH, Lu Y, et al. The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control. 2013;24(10):1821–36.

    PubMed  PubMed Central  Google Scholar 

  15. Zhao F, Copley B, Niu Q, Liu F, Johnson JA, Sutton T, et al. Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Res Treat. 2021;185(3):841–9.

    CAS  PubMed  Google Scholar 

  16. Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, et al. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer. 2013;13(1):1–11.

    Google Scholar 

  17. Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, et al. Characteristics associated with differences in survival among Black and White women with breast cancer. JAMA. 2013;310(4):389–97.

    CAS  PubMed  Google Scholar 

  18. Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Breast Cancer Res Treat. 2017;163(2):321–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Snyder RA, Hu C-Y, Zafar SN, Francescatti A, Chang GJ. Racial disparities in recurrence and overall survival in patients with locoregional colorectal cancer. J Natl Cancer Inst. 2021;113(6):770–7.

    PubMed  Google Scholar 

  20. White A, Joseph D, Rim SH, Johnson CJ, Coleman MP, Allemani C. Colon cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123:5014–36.

    PubMed  Google Scholar 

  21. Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, et al. Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: a United States population-based study. Gastroenterology. 2016;150(5):1135–46.

    PubMed  Google Scholar 

  22. Silber JH, Rosenbaum PR, Ross RN, Niknam BA, Ludwig JM, Wang W, et al. Racial disparities in colon cancer survival: a matched cohort study. Ann Intern Med. 2014;161(12):845–54.

    PubMed  Google Scholar 

  23. Valeri L, Chen JT, Garcia-Albeniz X, Krieger N, VanderWeele TJ, Coull BA. The role of stage at diagnosis in colorectal cancer black–white survival disparities: a counterfactual causal inference approach. Cancer Epidemiol Prev Biomark. 2016;25(1):83–9.

    Google Scholar 

  24. Chan C, Lopez A, Castaneda G, Bhuket T, Liu B, Yee S, et al. Black patients with colorectal cancer have more advanced cancer stage at time of diagnosis: a community-based safety-net hospital experience. J Commun Health. 2017;42(4):724–9.

    Google Scholar 

  25. Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hematol. 2010;76(1):44–52.

    PubMed  Google Scholar 

  26. Tao L, Gomez SL, Keegan TH, Kurian AW, Clarke CA. Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Prev Biomark. 2015;24(7):1039–45.

    CAS  Google Scholar 

  27. Guda K, Veigl ML, Varadan V, Nosrati A, Ravi L, Lutterbaugh J, et al. Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci USA. 2015;112(4):1149–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Li E, Ji P, Ouyang N, Zhang Y, Wang XY, Rubin DC, et al. Differential expression of miRNAs in colon cancer between African and Caucasian Americans: implications for cancer racial health disparities. Int J Oncol. 2014;45(2):587–94.

    PubMed  PubMed Central  Google Scholar 

  29. Curran T, Sun Z, Gerry B, Findlay VJ, Wallace K, Li Z, et al. Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities. Cancer Med. 2021;10(5):1805–14.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Wallace K, Lewin DN, Sun S, Spiceland CM, Rockey DC, Alekseyenko AV, et al. Tumor-infiltrating lymphocytes and colorectal cancer survival in African American and Caucasian patients. Cancer Epidemiol Prev Biomark. 2018;27(7):755–61.

    Google Scholar 

  31. Jovov B, Araujo-Perez F, Sigel CS, Stratford JK, McCoy AN, Yeh JJ, et al. Differential gene expression between African American and European American colorectal cancer patients. PLoS ONE. 2012;7(1):e30168.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Zhang C, Zhang C, Wang Q, Li Z, Lin J, Wang H. Differences in stage of cancer at diagnosis, treatment, and survival by race and ethnicity among leading cancer types. JAMA Netw Open. 2020;3(4):e202950.

    PubMed  PubMed Central  Google Scholar 

  33. Robbins HA, Engels EA, Pfeiffer RM, Shiels MS. Age at cancer diagnosis for blacks compared with whites in the United States. J Natl Cancer Inst. 2015;107(3):diu489.

    Google Scholar 

  34. Aizer AA, Wilhite TJ, Chen M-H, Graham PL, Choueiri TK, Hoffman KE, et al. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer. 2014;120(10):1532–9.

    PubMed  Google Scholar 

  35. Obeng-Gyasi S, Timsina L, Bhattacharyya O, Fisher CS, Haggstrom DA. Breast cancer presentation, surgical management and mortality across the rural–urban continuum in the national cancer database. Ann Surg Oncol. 2020;27(6):1805–15.

    PubMed  Google Scholar 

  36. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222–31.

    PubMed  Google Scholar 

  37. America Cancer Society. Cancer facts & figures for African-Americans 2019–2021. American Cancer Society; 2019.

    Google Scholar 

  38. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–51.

    PubMed  Google Scholar 

  39. Stapleton SM, Oseni TO, Bababekov YJ, Hung Y-C, Chang DC. Race/ethnicity and age distribution of breast cancer diagnosis in the United States. JAMA Surg. 2018;153(6):594–5.

    PubMed  PubMed Central  Google Scholar 

  40. Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol. 2018;15(3):408–14.

    PubMed  Google Scholar 

  41. Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221–38.

    PubMed  Google Scholar 

  42. Jackson DK, Li Y, Eskander MF, Tsung A, Oppong BA, Bhattacharyya O, et al. Racial disparities in low-value surgical care and time to surgery in high-volume hospitals. J Surg Oncol. 2021;123(2):676–86.

    PubMed  Google Scholar 

  43. Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong Y-N, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.

    PubMed  PubMed Central  Google Scholar 

  44. Restrepo DJ, Boczar D, Huayllani MT, Sisti A, Gabriel E, McLaughlin SA, et al. Influence of race, income, insurance, and education on the rate of breast reconstruction. Anticancer Res. 2019;39(6):2969–73.

    PubMed  Google Scholar 

  45. Relation T, Obeng-Gyasi S, Bhattacharyya O, Li Y, Eskander MF, Tsung A, et al. Racial differences in response to neoadjuvant chemotherapy: impact on breast and axillary surgical management. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09657-w.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Du XL, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17(1):122.

    Google Scholar 

  47. Parise CA, Bauer KR, Caggiano V. Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California. Cancer. 2012;118(9):2516–24.

    PubMed  Google Scholar 

  48. Wheeler SB, Carpenter WR, Peppercorn J, Schenck AP, Weinberger M, Biddle AK. Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients. Breast Cancer Res Treat. 2012;133(1):333–45.

    PubMed  PubMed Central  Google Scholar 

  49. Butler PD, Familusi O, Serletti JM, Fox JP. Influence of race, insurance status, and geographic access to plastic surgeons on immediate breast reconstruction rates. Am J Surg. 2018;215(6):987–94.

    PubMed  Google Scholar 

  50. Reeder A, Attar M, Nazario L, Bathula C, Zhang A, Hochbaum D, et al. Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage. Br J Cancer. 2015;112(9):1461–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2016;2(3):322–9.

    PubMed  PubMed Central  Google Scholar 

  52. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81(1):21–31.

    CAS  PubMed  Google Scholar 

  53. Schneider BP, Li L, Radovich M, Shen F, Miller KD, Flockhart DA, et al. Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199. Clin Cancer Res. 2015;21(22):5082–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Reeder-Hayes K, Hinton SP, Meng K, Carey LA, Dusetzina SB. Disparities in use of human epidermal growth hormone receptor 2-targeted therapy for early-stage breast cancer. J Clin Oncol. 2016;34(17):2003.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11(12):1135–41.

    CAS  PubMed  Google Scholar 

  56. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339(22):1609–18.

    CAS  PubMed  Google Scholar 

  57. Roberts MC, Wheeler SB, Reeder-Hayes K. Racial/ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review. Am J Public Health. 2015;105(Suppl 3):e4-15.

    PubMed  PubMed Central  Google Scholar 

  58. Albain KS, Gray RJ, Makower DF, Faghih A, Hayes DF, Geyer CE, et al. Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial. J Natl Cancer Inst. 2021;113(4):390–9.

    PubMed  Google Scholar 

  59. Sadigh G, Gray RJ, Sparano JA, Yanez B, Garcia SF, Timsina LR, et al. Breast cancer patients’ insurance status and residence zip code correlate with early discontinuation of endocrine therapy: an analysis of the ECOG-ACRIN TAILORx trial. Cancer. 2021. https://doi.org/10.1002/cncr.33527.

    Article  PubMed  Google Scholar 

  60. Makower D, Lin J, Xue X, Sparano JA. Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer. NPJ Breast Cancer. 2021;7(1):1–7.

    Google Scholar 

  61. Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of race/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women. JAMA Oncol. 2021;7(3):370–8.

    PubMed  Google Scholar 

  62. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gasterenterol. 2009;104(3):739–50.

    Google Scholar 

  63. National Center for Health Statistics. National Health Survery, 2015. Public-use data file and documentation. 2015 [cited 20 Mar 2021]. https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fnchs%2Fnhis%2Fquest_data_related_1997_forward.html.

  64. National Center for Health Statistics. National health interview survery, 2000 [cited 20 Mar 2021]. https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fnchs%2Fnhis%2Fquest_data_related_1997_forward.htm.

  65. Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7(Suppl 1):S32.

    PubMed  PubMed Central  Google Scholar 

  66. Andersen SW, Blot WJ, Lipworth L, Steinwandel M, Murff HJ, Zheng W. Association of race and socioeconomic status with colorectal cancer screening, colorectal cancer risk, and mortality in southern US adults. JAMA Netw Open. 2019;2(12):e1917995.

    Google Scholar 

  67. Halbert CH, Armstrong K, Gandy OH, Shaker L. Racial differences in trust in health care providers. Arch Intern Med. 2006;166(8):896–901.

    PubMed  Google Scholar 

  68. Khankari K, Eder M, Osborn CY, Makoul G, Clayman M, Skripkauskas S, et al. Improving colorectal cancer screening among the medically underserved: a pilot study within a federally qualified health center. J Gen Intern Med. 2007;22(10):1410–4.

    PubMed  PubMed Central  Google Scholar 

  69. Naylor K, Ward J, Polite BN. Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med. 2012;27(8):1033–46.

    PubMed  PubMed Central  Google Scholar 

  70. Tramontano AC, Chen Y, Watson TR, Eckel A, Hur C, Kong CY. Racial/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000–2014. PLoS ONE. 2020;15(4):e0231599.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Sineshaw HM, Ng K, Flanders WD, Brawley OW, Jemal A. Factors that contribute to differences in survival of black vs white patients with colorectal cancer. Gastroenterology. 2018;154(4):906-915.e7.

    PubMed  Google Scholar 

  72. Gill AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, et al. Colon cancer treatment: are there racial disparities in an equal-access healthcare system? Dis Colon Rectum. 2014;57(9):1059.

    PubMed  PubMed Central  Google Scholar 

  73. Breslin TM, Morris AM, Gu N, Wong SL, Finlayson EV, Banerjee M, et al. Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J Clin Oncol. 2009;27(24):3945.

    PubMed  PubMed Central  Google Scholar 

  74. Eaglehouse YL, Georg MW, Shriver CD, Zhu K. Racial comparisons in timeliness of colon cancer treatment in an equal-access health system. J Natl Cancer Inst. 2020;112(4):410–7.

    PubMed  Google Scholar 

  75. Rhoads KF, Patel MI, Ma Y, Schmidt LA. How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol. 2015;33(8):854.

    PubMed  PubMed Central  Google Scholar 

  76. Laryea JA, Siegel E, Klimberg S. Racial disparity in colorectal cancer: the role of equal treatment. Dis Colon Rectum. 2014;57(3):295–302.

    PubMed  Google Scholar 

  77. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

    Google Scholar 

  78. Haddad DN, Sandler KL, Henderson LM, Rivera MP, Aldrich MC. Disparities in lung cancer screening: a review. Ann Am Thorac Soc. 2020;17(4):399–405.

    PubMed  PubMed Central  Google Scholar 

  79. Annangi S, Nutalapati S, Foreman MG, Pillai R, Flenaugh EL. Potential racial disparities using current lung cancer screening guidelines. J Racial Ethn Health Disparities. 2019;6(1):22–6.

    PubMed  Google Scholar 

  80. Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021;325(10):962–70.

    PubMed  Google Scholar 

  81. Wolf A, Alpert N, Tran BV, Liu B, Flores R, Taioli E. Persistence of racial disparities in early-stage lung cancer treatment. J Thorac Cardiovasc Surg. 2019;157(4):1670-1679.e4.

    PubMed  Google Scholar 

  82. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198–205.

    CAS  PubMed  Google Scholar 

  83. Taioli E, Flores R. Appropriateness of surgical approach in black patients with lung cancer—15 years later, little has changed. J Thorac Oncol. 2017;12(3):573–7.

    PubMed  Google Scholar 

  84. Fang P, He W, Gomez D, Hoffman KE, Smith BD, Giordano SH, et al. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol. 2018;3(3):221–9.

    PubMed  PubMed Central  Google Scholar 

  85. Lin JJ, Mhango G, Wall MM, Lurslurchachai L, Bond KT, Nelson JE, et al. Cultural factors associated with racial disparities in lung cancer care. Ann Am Thorac Soc. 2014;11(4):489–95.

    PubMed  PubMed Central  Google Scholar 

  86. Palmer JR, Polley EC, Hu C, John EM, Haiman C, Hart SN, et al. Contribution of germline predisposition gene mutations to breast cancer risk in African American women. JNCI J Natl Cancer Inst. 2020;112(12):1213–21.

    PubMed  Google Scholar 

  87. Zheng Y, Zhang J, Niu Q, Huo D, Olopade OI. Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer. 2012;118(5):1362–70.

    CAS  PubMed  Google Scholar 

  88. Wang S, Pitt JJ, Zheng Y, Yoshimatsu TF, Gao G, Sanni A, et al. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria. Int J Cancer. 2019;145(12):3321–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Jones CC, Bush WS, Crawford DC, Wenzlaff AS, Schwartz AG, Wiencke JK, et al. Germline genetic variants and lung cancer survival in African Americans. Cancer Epidemiol Biomark Prev. 2017;26(8):1288–95.

    CAS  Google Scholar 

  90. Schenk A, López S, Kschischo M, McGranahan N. Germline ancestry influences the evolutionary disease course in lung adenocarcinomas. Evol Appl. 2020;13(7):1550–7.

    PubMed  PubMed Central  Google Scholar 

  91. Campbell JD, Lathan C, Sholl L, Ducar M, Vega M, Sunkavalli A, et al. Comparison of prevalence and types of mutations in lung cancers among Black and White populations. JAMA Oncol. 2017;3(6):801–9.

    PubMed  PubMed Central  Google Scholar 

  92. Hebbring SJ, Adjei AA, Baer JL, Jenkins GD, Zhang J, Cunningham JM, et al. Human SULT1A1 gene: copy number differences and functional implications. Hum Mol Genet. 2007;16(5):463–70.

    CAS  PubMed  Google Scholar 

  93. Weber TK, Chin H-M, Rodriguez-Bigas M, Keitz B, Gilligan R, O’Malley L, et al. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA. 1999;281(24):2316–20.

    CAS  PubMed  Google Scholar 

  94. Guindalini RSC, Win AK, Gulden C, Lindor NM, Newcomb PA, Haile RW, et al. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. 2015;149(6):1446–53.

    CAS  PubMed  Google Scholar 

  95. Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, et al. Genomic regions associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma in African Americans: the cross BETRNet admixture study. PloS One. 2017;12(10):e0184962.

    PubMed  PubMed Central  Google Scholar 

  96. Bryc K, Durand EY, Macpherson JM, Reich D, Mountain JL. The genetic ancestry of African Americans, Latinos, and European Americans across the United States. Am J Hum Genet. 2015;96(1):37–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Mohammed SI, Springfield S, Das R. Role of epigenetics in cancer health disparities. Methods Mol Biol. 2012;863:395–410.

    CAS  PubMed  Google Scholar 

  98. Ahmad A, Azim S, Zubair H, Khan MA, Singh S, Carter JE, et al. Epigenetic basis of cancer health disparities: looking beyond genetic differences. Biochim Biophys Acta-Rev Cancer. 2017;1868(1):16–28.

    CAS  PubMed  Google Scholar 

  99. Lerner L, Winn R, Hulbert A. Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity. J Thorac Dis. 2018;10(4):2498.

    PubMed  PubMed Central  Google Scholar 

  100. Thayer ZM, Kuzawa CW. Biological memories of past environments: epigenetic pathways to health disparities. Epigenetics. 2011;6(7):798–803.

    PubMed  Google Scholar 

  101. Carlson ED, Chamberlain RM. Allostatic load and health disparities: a theoretical orientation. Res Nurs Health. 2005;28(4):306–15.

    CAS  PubMed  Google Scholar 

  102. Rodriquez EJ, Kim EN, Sumner AE, Nápoles AM, Pérez-Stable EJ. Allostatic load: Importance, markers, and score determination in minority and disparity populations. J Urban Health. 2019;96(1):3–11.

    PubMed  PubMed Central  Google Scholar 

  103. Olden K, Lin Y-S, Bussard D. Epigenome: a biomarker or screening tool to evaluate health impact of cumulative exposure to chemical and non-chemical stressors. Biosensors. 2016;6(2):12.

    PubMed Central  Google Scholar 

  104. Cunliffe VT. The epigenetic impacts of social stress: how does social adversity become biologically embedded? Epigenomics. 2016;8(12):1653–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  105. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415–28.

    CAS  PubMed  Google Scholar 

  106. Grønbaek K, Hother C, Jones PA. Epigenetic changes in cancer. Apmis. 2007;115(10):1039–59.

    PubMed  Google Scholar 

  107. Lara OD, Wang Y, Asare A, Xu T, Chiu H-S, Liu Y, et al. Pan-cancer clinical and molecular analysis of racial disparities. Cancer. 2020;126(4):800–7.

    CAS  PubMed  Google Scholar 

  108. Nesset KA, Perri AM, Mueller CR. Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors. Epigenetics. 2014;9(6):851–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  109. Ambrosone CB, Young AC, Sucheston LE, Wang D, Li Y, Liu S, et al. Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget. 2014;5(1):237.

    PubMed  Google Scholar 

  110. Mehrotra A, Liu H, Adams JL, Wang MC, Lave JR, Thygeson NM, et al. Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses. Ann Intern Med. 2009;151(5):321–8.

    PubMed  PubMed Central  Google Scholar 

  111. Mokarram P, Kumar K, Brim H, Naghibalhossaini F, Saberi-firoozi M, Nouraie M, et al. Distinct high-profile methylated genes in colorectal cancer. PLoS ONE. 2009;4(9):e7012.

    PubMed  PubMed Central  Google Scholar 

  112. Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL, et al. Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res. 2009;15(4):1155–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  113. Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, et al. Comparison of breast cancer molecular features and survival by African and European Ancestry in The Cancer Genome Atlas. JAMA Oncol. 2017;3(12):1654–62.

    PubMed  PubMed Central  Google Scholar 

  114. Charan M, Verma AK, Hussain S, Misri S, Mishra S, Majumder S, et al. Molecular and cellular factors associated with racial disparity in breast cancer. Int J Mol Sci. 2020;21(16):5946.

    Google Scholar 

  115. Saini G, Ogden A, McCullough LE, Torres M, Rida P, Aneja R. Disadvantaged neighborhoods and racial disparity in breast cancer outcomes: the biological link. Cancer Causes Control. 2019;30(7):677–86.

    PubMed  PubMed Central  Google Scholar 

  116. Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011;3(4):503–18.

    CAS  PubMed  Google Scholar 

  117. Sharavanan VJ, Sivaramakrishnan M, Sivarajasekar N, Senthilrani N, Kothandan R, Dhakal N, et al. Pollutants inducing epigenetic changes and diseases. Environ Chem Lett. 2020;18(2):325–43.

    CAS  Google Scholar 

  118. Vidal AC, Neelon SEB, Liu Y, Tuli AM, Fuemmeler BF, Hoyo C, et al. Maternal stress, preterm birth, and DNA methylation at imprint regulatory sequences in humans. Genet Epigenetics. 2014;6:37–44.

    CAS  Google Scholar 

  119. Hoare J, Stein DJ, Heany SJ, Fouche J-P, Phillips N, Er S, et al. Accelerated epigenetic aging in adolescents from low-income households is associated with altered development of brain structures. Metab Brain Dis. 2020;35(8):1287–98.

    CAS  PubMed  Google Scholar 

  120. Pasculli B, Barbano R, Parrella P. Epigenetics of breast cancer: biology and clinical implication in the era of precision medicine. Semin Cancer Biol. 2018;51:22–35.

    PubMed  Google Scholar 

  121. Al Hadidi S, Mims M, Miller-Chism CN, Kamble R. Participation of African American persons in clinical trials supporting US food and drug administration approval of cancer drugs. Ann Intern Med. 2020;173(4):320–2.

    PubMed  Google Scholar 

  122. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153(18):2093–101.

    CAS  PubMed  Google Scholar 

  123. Kinlein SA, Wilson CD, Karatsoreos IN. Dysregulated hypothalamic–pituitary–adrenal axis function contributes to altered endocrine and neurobehavioral responses to acute stress. Front Psychiatry. 2015;6:31.

    PubMed  PubMed Central  Google Scholar 

  124. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation—allostatic load and its health consequences: MacArthur studies of successful aging. Arch Intern Med. 1997;157(19):2259–68.

    CAS  PubMed  Google Scholar 

  125. Mathew A, Doorenbos AZ, Li H, Jang MK, Park CG, Bronas UG. Allostatic load in cancer: a systematic review and mini meta-analysis. Biol Res Nurs. 2020. https://doi.org/10.1177/1099800420969898.

    Article  PubMed  Google Scholar 

  126. Parente V, Hale L, Palermo T. Association between breast cancer and allostatic load by race: National Health and Nutrition Examination Survey 1999–2008. Psychooncology. 2013;22(3):621–8.

    PubMed  Google Scholar 

  127. Akinyemiju T, Wilson LE, Deveaux A, Aslibekyan S, Cushman M, Gilchrist S, et al. Association of allostatic load with all-cause and cancer mortality by race and body mass index in theREGARDS cohort. Cancers (Basel). 2020;12(6):1695.

    CAS  PubMed Central  Google Scholar 

  128. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  129. Morgan XC, Huttenhower C. Human microbiome analysis. PLoS Comput Biol. 2012;8(12):e1002808.

    CAS  PubMed  PubMed Central  Google Scholar 

  130. Malard F, Dore J, Gaugler B, Mohty M. Introduction to host microbiome symbiosis in health and disease. Mucosal Immunol. 2021;14(3):547–54.

    CAS  PubMed  Google Scholar 

  131. Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400.

    CAS  PubMed  PubMed Central  Google Scholar 

  132. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35(2):249–55.

    CAS  PubMed  Google Scholar 

  133. Hester CM, Jala VR, Langille MG, Umar S, Greiner KA, Haribabu B. Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups. World J Gastroenterol. 2015;21(9):2759–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  134. Sengupta S, Muir JG, Gibson PR. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol. 2006;21(1):209–18.

    CAS  PubMed  Google Scholar 

  135. Gonçalves P, Martel F. Butyrate and colorectal cancer: the role of butyrate transport. Curr Drug Metab. 2013;14(9):994–1008.

    PubMed  Google Scholar 

  136. Farhana L, Antaki F, Murshed F, Mahmud H, Judd SL, Nangia-Makker P, et al. Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans. World J Gastrointest Pathophysiol. 2018;9(2):47–58.

    PubMed  PubMed Central  Google Scholar 

  137. Shang F-M, Liu H-L. Fusobacterium nucleatum and colorectal cancer: a review. World J Gastrointest Oncol. 2018;10(3):71.

    PubMed  PubMed Central  Google Scholar 

  138. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548-563.e16.

    CAS  PubMed  PubMed Central  Google Scholar 

  139. Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65(12):1973–80.

    CAS  PubMed  Google Scholar 

  140. Thyagarajan S, Zhang Y, Thapa S, Allen MS, Phillips N, Chaudhary P, et al. Comparative analysis of racial differences in breast tumor microbiome. Sci Rep. 2020;10(1):1–13.

    Google Scholar 

  141. Smith A, Pierre JF, Makowski L, Tolley E, Lyn-Cook B, Lu L, et al. Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women. Sci Rep. 2019;9(1):11940.

    PubMed  PubMed Central  Google Scholar 

  142. Wu S, Powers S, Zhu W, Hannun YA. Substantial contribution of extrinsic risk factors to cancer development. Nature. 2016;529(7584):43–7.

    CAS  PubMed  Google Scholar 

  143. Spring B, King AC, Pagoto SL, Van Horn L, Fisher JD. Fostering multiple healthy lifestyle behaviors for primary prevention of cancer. Am Psychol. 2015;70(2):75.

    PubMed  PubMed Central  Google Scholar 

  144. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology. 2010;138(6):2029-2043.e10.

    CAS  PubMed  Google Scholar 

  145. Bellanger M, Barry K, Rana J, Regnaux J-P. Cost-effectiveness of lifestyle-related interventions for the primary prevention of breast cancer: a rapid review. Front Med. 2020;6:325.

    Google Scholar 

  146. Gonzalez CA. Nutrition and cancer: the current epidemiological evidence. Br J Nutr. 2006;96(Suppl 1):S42–5.

    CAS  PubMed  Google Scholar 

  147. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3(1):1–21.

    Google Scholar 

  148. Key TJ, Bradbury KE, Perez-Cornago A, Sinha R, Tsilidis KK, Tsugane S. Diet, nutrition, and cancer risk: what do we know and what is the way forward? BMJ. 2020;368:m511.

    PubMed  PubMed Central  Google Scholar 

  149. Bahr PR. Race and nutrition: an investigation of Black-White differences in health-related nutritional behaviours. Sociol Health Illn. 2007;29(6):831–56.

    PubMed  Google Scholar 

  150. Thompson TL, Singleton CR, Springfield SE, Thorpe RJ Jr, Odoms-Young A. Differences in nutrient intake and diet quality between non-Hispanic black and non-Hispanic white men in the United States. Public Health Rep. 2020;135(3):334–42.

    PubMed  PubMed Central  Google Scholar 

  151. Bartley K, Jung M, Yi S. Diet and blood pressure: differences among whites, blacks and Hispanics in New York City 2010. Ethn Dis. 2014;24(2):175–81.

    PubMed  Google Scholar 

  152. Airhihenbuwa CO, Kumanyika S, Agurs TD, Lowe A, Saunders D, Morssink CB. Cultural aspects of African American eating patterns. Ethn Health. 1996;1(3):245–60.

    CAS  PubMed  Google Scholar 

  153. Semmes CE. Racism, health, and post-industrialism: a theory of African-American health. 1996.

  154. Vance KE. Culture, food, and racism: the effects on African American health. 2018.

  155. Hargreaves MK, Schlundt DG, Buchowski MS. Contextual factors influencing the eating behaviours of African American women: a focus group investigation. Ethn Health. 2002;7(3):133–47.

    PubMed  Google Scholar 

  156. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008;60(2):131–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  157. Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Chao A, Patel AV, et al. Meat consumption among Black and White men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Prev Biomark. 2006;15(2):211–6.

    Google Scholar 

  158. Yazici C, Wolf PG, Kim H, Cross T-WL, Vermillion K, Carroll T, et al. Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut. 2017;66(11):1983–94.

    CAS  PubMed  Google Scholar 

  159. Storey M, Anderson P. Income and race/ethnicity influence dietary fiber intake and vegetable consumption. Nutr Res. 2014;34(10):844–50.

    CAS  PubMed  Google Scholar 

  160. Kunzmann AT, Coleman HG, Huang W-Y, Kitahara CM, Cantwell MM, Berndt SI. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Clin Nutr. 2015;102(4):881–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  161. Heaney RP. Low calcium intake among African Americans: effects on bones and body weight. J Nutr. 2006;136(4):1095–8.

    CAS  PubMed  Google Scholar 

  162. Yang Q-H, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am J Clin Nutr. 2007;85(5):1409–16.

    CAS  PubMed  Google Scholar 

  163. Boggs DA, Palmer JR, Wise LA, Spiegelman D, Stampfer MJ, Adams-Campbell LL, et al. Fruit and vegetable intake in relation to risk of breast cancer in the Black Women’s Health Study. Am J Epidemiol. 2010;172(11):1268–79.

    PubMed  PubMed Central  Google Scholar 

  164. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556.

    PubMed  PubMed Central  Google Scholar 

  165. Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23(38):6365–78.

    CAS  PubMed  Google Scholar 

  166. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3(9):565–74.

    PubMed  Google Scholar 

  167. Liu B, Du Y, Wu Y, Snetselaar LG, Wallace RB, Bao W. Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011–18: population based study. BMJ. 2021;372:n365.

    PubMed  PubMed Central  Google Scholar 

  168. Samanic C, Gridley G, Chow W-H, Lubin J, Hoover RN, Fraumeni JFJ. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control. 2004;15(1):35–43.

    PubMed  Google Scholar 

  169. Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(1):307–14.

    PubMed  Google Scholar 

  170. Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat. 2006;97(3):245–54.

    PubMed  Google Scholar 

  171. Jiang M, Fares AF, Shepshelovich D, Yang P, Christiani D, Zhang J, et al. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer. 2021;152:58–65.

    PubMed  Google Scholar 

  172. Westerlind KC. Physical activity and cancer prevention—mechanisms. Med Sci Sports Exerc. 2003;35(11):1834–40.

    PubMed  Google Scholar 

  173. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD. Physical activity and cancer prevention. Sports Med. 2008;38(4):271–96.

    PubMed  Google Scholar 

  174. Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27(1):10–21.

    CAS  PubMed  Google Scholar 

  175. August KJ, Sorkin DH. Racial/ethnic disparities in exercise and dietary behaviors of middle-aged and older adults. J Gen Intern Med. 2011;26(3):245–50.

    PubMed  Google Scholar 

  176. Joseph RP, Ainsworth BE, Keller C, Dodgson JE. Barriers to Physical activity among African American women: an integrative review of the literature. Women Health. 2015;55(6):679–99.

    PubMed  PubMed Central  Google Scholar 

  177. Wen M, Zhang X, Harris CD, Holt JB, Croft JB. Spatial disparities in the distribution of parks and green spaces in the USA. Ann Behav Med. 2013;45(Suppl 1):S18-27.

    PubMed  Google Scholar 

  178. LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ. Alcohol and cancer: a statement of the American Society of Clinical Oncology. J Clin Oncol. 2018;36(1):83–93.

    CAS  PubMed  Google Scholar 

  179. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005;116(6):963–71.

    CAS  PubMed  Google Scholar 

  180. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391(6):603–13.

    PubMed  Google Scholar 

  181. Agaku IT, King BA, Dube SR. Current cigarette smoking among adults—United States, 2005–2012. MMWR Morb Mortal Wkly Rep. 2014;63(2):29–34.

    PubMed  PubMed Central  Google Scholar 

  182. Holford TR, Levy DT, Meza R. Comparison of Smoking History Patterns Among African American and White Cohorts in the United States Born 1890 to 1990. Nicotine Tob Res. 2016;18(Suppl 1):S16-29.

    PubMed  PubMed Central  Google Scholar 

  183. Hooks-Anderson DR, Salas J, Secrest S, Skiöld-Hanlin S, Scherrer JF. Association between race and receipt of counselling or medication for smoking cessation in primary care. Fam Pract. 2018;35(2):160–5.

    PubMed  Google Scholar 

  184. Hooper MW, Asfar T, Unrod M, Dorsey A, Correa JB, Brandon KO, et al. Reasons for exclusion from a smoking cessation trial: an analysis by race/ethnicity. Ethn Dis. 2019;29(1):23.

    Google Scholar 

  185. Perez-Stable EJ, Herrera B, Jacob P III, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280(2):152–6.

    CAS  PubMed  Google Scholar 

  186. Ho JY, Elo IT. The contribution of smoking to black–white differences in U.S. mortality. Demography. 2013;50(2):545–68.

    PubMed  Google Scholar 

  187. Assari S, Bazargan M. Unequal effects of educational attainment on workplace exposure to second-hand smoke by race and ethnicity; minorities’ diminished returns in the National Health Interview Survey (NHIS). J Med Res Innov. 2019;3(2):e000179.

    PubMed  PubMed Central  Google Scholar 

  188. Homa DM, Neff LJ, King BA, Caraballo RS, Bunnell RE, Babb SD, et al. Vital signs: disparities in nonsmokers’ exposure to secondhand smoke—United States, 1999–2012. MMWR Morb Mortal Wkly Rep. 2015;64(4):103–8.

    PubMed  PubMed Central  Google Scholar 

  189. Adie Y, Kats DJ, Tlimat A, Perzynski A, Dalton J, Gunzler D, et al. Neighborhood disadvantage and lung cancer incidence in ever-smokers at a safety net health-care system: a retrospective study. Chest. 2020;157(4):1021–9.

    PubMed  Google Scholar 

  190. De la Roca J, Ellen IG, O’Regan KM. Race and neighborhoods in the 21st century: what does segregation mean today? Reg Sci Urban Econ. 2014;47:138–51.

    Google Scholar 

  191. Buehler JW, Castro JC, Cohen S, Zhao Y, Melly S, Moore K. Personal and neighborhood attributes associated with cervical and colorectal cancer screening in an urban African American population. Prev Chronic Dis. 2019;29(16):E118.

    Google Scholar 

  192. Johnson AM, Johnson A, Hines RB, Mohammadi R. Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicity. Lung Cancer. 2020;142:20–7.

    PubMed  Google Scholar 

  193. Landrine H, Corral I, Lee JGL, Efird JT, Hall MB, Bess JJ. Residential segregation and racial cancer disparities: a systematic review. J Racial Ethn Health Disparities. 2017;4(6):1195–205.

    PubMed  Google Scholar 

  194. Amobi A, Plescia M, Alexander-Scott N. The business case for investing in place-based public health initiatives. J Public Health Manag Pract. 2019;25(6):612–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Johns Hopkins University, Baltimore, MD, USA

    Wasay Nizam MD, Malcolm V. Brock MD & Fabian M. Johnston MD, MHS

  2. Department of Surgery, Weill Cornell Medicine, New York, NY, USA

    Heather L. Yeo MHS, MD, MBA, MS

  3. Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA

    Samilia Obeng-Gyasi MD, MPH

  4. Division of Gastrointestinal Surgical Oncology, Peritoneal Surface Malignancy Program, Complex General Surgical Oncology Fellowship, Division of Surgical Oncology, Johns Hopkins University, Baltimore, MD, USA

    Fabian M. Johnston MD, MHS

Authors
  1. Wasay Nizam MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heather L. Yeo MHS, MD, MBA, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samilia Obeng-Gyasi MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Malcolm V. Brock MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fabian M. Johnston MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabian M. Johnston MD, MHS.

Ethics declarations

Disclosures

Samilia Obeng-Gyasi is funded by the Paul Calabresi Career Development Award (K12 CA133250). Wasay Nizam, Heather L. Yeo, Malcolm V. Brock, and Fabian M. Johnston have no disclosures to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nizam, W., Yeo, H.L., Obeng-Gyasi, S. et al. Disparities in Surgical Oncology: Management of Advanced Cancer. Ann Surg Oncol 28, 8056–8073 (2021). https://doi.org/10.1245/s10434-021-10275-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10275-9

Search

Navigation